Literature DB >> 8879887

Etiologies and sequelae of excessive daytime sleepiness.

T Roth1, T A Roehrs.   

Abstract

Excessive daytime sleepiness (EDS), the primary complaint of patients seen in sleep clinics, affects up to 12% of the general population. The effects of EDS can be debilitating and even life threatening. Patients with EDS may exhibit psychosocial distress, decreased work or school performance, and increased risk for accidents. The differential diagnosis of EDS requires objective assessments, such as polysomnography and the Multiple Sleep Latency Test. There are four major causes of EDS: (1) central nervous system (CNS) pathologic abnormalities, such as narcolepsy and idiopathic CNS hypersomnia; (2) qualitative or quantitative sleep deficiencies, such as sleep apnea and insufficient nocturnal sleep; (3) misalignments of the body's circadian pacemaker with the environment (eg. jet lag or shift work); and (4) drugs, which can increase sleepiness either therapeutically or as a side effect. Depending on etiology, management strategies for EDS include extension of time in bed, naps, surgery, various medical devices (eg, oral appliances, continuous positive airway pressure), and pharmacotherapy. Pharmacotherapy is generally achieved with stimulants, such as amphetamine sulfate, methylphenidate, and pemoline or newer, safer compounds like modafinil.

Entities:  

Mesh:

Year:  1996        PMID: 8879887     DOI: 10.1016/s0149-2918(96)80207-4

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  33 in total

1.  Association of current work and sleep situations with excessive daytime sleepiness and medical incidents among Japanese physicians.

Authors:  Yoshitaka Kaneita; Takashi Ohida
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

2.  Modafinil in sports: ethical considerations.

Authors:  K R Kaufman
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

3.  Modafinil for the treatment of cocaine dependence.

Authors:  Ann L Anderson; Malcolm S Reid; Shou-Hua Li; Tyson Holmes; Lynn Shemanski; April Slee; Edwina V Smith; Roberta Kahn; Nora Chiang; Frank Vocci; Domenic Ciraulo; Charles Dackis; John D Roache; Ihsan M Salloum; Eugene Somoza; Harold C Urschel; Ahmed M Elkashef
Journal:  Drug Alcohol Depend       Date:  2009-06-26       Impact factor: 4.492

4.  Antipsychotic-induced somnolence in mothers with schizophrenia.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2012-03

5.  Excessive daytime sleepiness and napping in cognitively normal adults: associations with subsequent amyloid deposition measured by PiB PET.

Authors:  Adam P Spira; Yang An; Mark N Wu; Jocelynn T Owusu; Eleanor M Simonsick; Murat Bilgel; Luigi Ferrucci; Dean F Wong; Susan M Resnick
Journal:  Sleep       Date:  2018-10-01       Impact factor: 5.849

6.  Inter-critical and critical excessive daily sleepiness in episodic migraine patients.

Authors:  S Gori; C Lucchesi; M R Maluccio; N Morelli; M Maestri; E Bonanni; L Murri
Journal:  Neurol Sci       Date:  2012-01-15       Impact factor: 3.307

7.  Non-pharmacological self-management of sleep among the Japanese general population.

Authors:  Sayaka Aritake-Okada; Yoshitaka Kaneita; Makoto Uchiyama; Kazuo Mishima; Takashi Ohida
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

Review 8.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 9.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Modafinil in the treatment of excessive sleepiness.

Authors:  Jonathan R L Schwartz
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.